Larimar Therapeutics Stock In The News
| LRMR Stock | USD 6.33 0.31 4.67% |
Our overall analysis of Larimar Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Larimar Therapeutics. The specific impact of Larimar Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Larimar Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Larimar Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Larimar Therapeutics Backtesting and Larimar Therapeutics Hype Analysis. To learn how to invest in Larimar Stock, please use our How to Invest in Larimar Therapeutics guide.
Larimar |
Larimar Therapeutics Today Top News and Investor Outlook
Larimar Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Larimar and other traded companies coverage with news coverage. We help investors stay connected with Larimar headlines for the 1st of December to make an informed investment decision based on correlating the impacts of news items on Larimar Stock performance. Please note that trading solely based on the Larimar Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Larimar Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Larimar earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Larimar Therapeutics that are available to investors today. That information is available publicly through Larimar media outlets and privately through word of mouth or via Larimar internal channels. However, regardless of the origin, that massive amount of Larimar data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Larimar Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Larimar Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Larimar Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Larimar Therapeutics alpha.
Larimar Largest EPS Surprises
Earnings surprises can significantly impact Larimar Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-09 | 2024-03-31 | -0.23 | -0.27 | -0.04 | 17 | ||
2024-03-14 | 2023-12-31 | -0.25 | -0.3 | -0.05 | 20 | ||
2022-11-10 | 2022-09-30 | -0.42 | -0.37 | 0.05 | 11 | ||
2023-05-15 | 2023-03-31 | -0.25 | -0.15 | 0.1 | 40 | ||
2022-08-11 | 2022-06-30 | -0.57 | -0.47 | 0.1 | 17 | ||
2021-05-10 | 2021-03-31 | -0.86 | -0.76 | 0.1 | 11 |
Larimar Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Larimar Therapeutics Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
26th of November 2024
Acquisition by Everett Wendy of 27000 shares of Larimar Therapeutics at 1.25 subject to Ru... at MacroaxisInsider
18th of November 2024
Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Explor... at gurufocus.com
15th of November 2024
Blue Owl Capital Holdings LP Adjusts Stake in Cullinan Therapeutics Inc at gurufocus.com
11th of November 2024
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance at zacks.com
1st of November 2024
Larimar Therapeutics Inc Reports Q3 2024 Net Loss of 15.5 Million, EPS of -0. ... at gurufocus.com
17th of October 2024
Companies Like Larimar Therapeutics Are In A Position To Invest In Growth at finance.yahoo.com
3rd of October 2024
Larimar started at outperform by Wedbush on FA drug candidate at seekingalpha.com
19th of September 2024
Larimar Therapeutics Announces Three Poster Presentations at the Upcoming International Co... at finance.yahoo.com
9th of September 2024
Insider Trading at MacroaxisInsider
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Larimar Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Larimar Therapeutics' short interest history, or implied volatility extrapolated from Larimar Therapeutics options trading.
Additional Tools for Larimar Stock Analysis
When running Larimar Therapeutics' price analysis, check to measure Larimar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Larimar Therapeutics is operating at the current time. Most of Larimar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Larimar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Larimar Therapeutics' price. Additionally, you may evaluate how the addition of Larimar Therapeutics to your portfolios can decrease your overall portfolio volatility.